GenMark Diagnostics (GNMK) – Analyst Comments
-
Canaccord Genuity Sees GenMark Diagnostics (GNMK) Trading Above Buyout Comps, PT Raised to $24
-
Buy Weakness in MDx Stocks Following Abbott Test-Related Sell-Off - Cowen
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to GNMK Stock Lookup